Molecular testing for the clinical diagnosis of fibrolamellar carcinoma

Autor: Dhanpat Jain, Luigi Terracciano, Sarah E. Kerr, Riyam T. Zreik, Stephanie Roessler, Venancio Alves, William R. Sukov, Michael Cruise, Thomas Longerich, Jeanette G Rustin, Lewis R. Roberts, Xiaoke Wang, Peter Schirmacher, Ryan M. Gill, Safia N. Salaria, Funda Yilmaz, Nida Zaid, Patricia T. Greipp, Dora Lam-Himlin, Long Jin, Deniz Nart, Rondell P. Graham, Sanjay Kakar, David A. Solomon, Linda D. Ferrell, Michael Torbenson, Matthew M. Yeh, Emily G. Waterhouse

Publikováno v: Modern pathology 31(1), 141-149 (2018). doi:10.1038/modpathol.2017.103
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, vol 31, iss 1
Modern Pathology

WOS: 000419766500013
PubMed ID: 28862261
Fibrolamellar carcinoma has a distinctive morphology and immunophenotype, including cytokeratin 7 and CD68 co-expression. Despite the distinct findings, accurate diagnosis of fibrolamellar carcinoma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bb3162f25621d6d823ecc9f8689f958
https://publications.rwth-aachen.de/record/757627